ShareholdingJun 1, 2026, 10:13 AM
AstraZeneca Reports 1,551,009,750 Total Voting Rights
AI Summary
AstraZeneca PLC announced its total voting rights as of May 31, 2026. The company's issued share capital with voting rights stands at 1,551,009,750 ordinary shares of US$0.25, with no shares held in Treasury. This figure is provided for shareholders to determine their notification obligations under the UK Financial Conduct Authority's Disclosure and Transparency Rules.
Key Highlights
- AstraZeneca reported total voting rights of 1,551,009,750 as of May 31, 2026.
- The issued share capital with voting rights consists of 1,551,009,750 ordinary shares.
- Each ordinary share has a nominal value of US$0.25.
- No shares are currently held in Treasury.
- The figure is for shareholders to comply with UK FCA Disclosure and Transparency Rules.
Price Impact
More from AZN